Aaron Deykin, Chief Medical Officer at Upstream Bio, Inc. (UPB), sold 895 shares at $5.49 ($5K) on 2026-09-16, disclosed to the SEC on 2026-09-17.
Open-market sale of $5k UPB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |